×
About 6,140 results

ALLMedicine™ Erythrocyte Sedimentation Rate Center

Research & Reviews  2,033 results

Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627273
Drug Design, Development and Therapy; Yang XM, Jia YL et. al.

Dec 2nd, 2021 - The purpose of this study was to determine the clinical value of triple antibiotic therapy consisting of doxycycline, compound sulfamethoxazole and rifampicin in the treatment of brucellosis spondylitis. A retrospective analysis was performed on 1...

Can the leukocyte esterase strip test predict persistence of periprosthetic joint infec...
https://doi.org/10.1016/j.arth.2021.11.022
The Journal of Arthroplasty; Logoluso N, Pellegrini A et. al.

Nov 26th, 2021 - We evaluated the reliability of intraoperative assessment of leukocyte esterase (LE) in synovial fluid samples from patients undergoing reimplantation following implant removal and spacer insertion for periprosthetic joint infection (PJI). Our hyp...

Pediatric pneumonia (PedPne) lung ultrasound score and inflammatory markers: A pilot st...
https://doi.org/10.1002/ppul.25760
Pediatric Pulmonology; Ciuca IM, Dediu M et. al.

Nov 18th, 2021 - Pneumonia is the principal cause of death among children worldwide. Lung ultrasound (LUS) is a reliable tool for the diagnosis and assessment of community-acquired pneumonia in children. Furthermore, objective parameters, including the pneumonia L...

see more →

Guidelines  2 results

AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant ...
https://doi.org/10.1053/j.gastro.2019.06.014
Gastroenterology Carrasco-Labra A, Lytvyn L et. al.

Jul 29th, 2019 - The evaluation of patients with chronic watery diarrhea represents a diagnostic challenge for clinicians because organic causes, including inflammatory bowel disease, microscopic colitis, and chronic infection, must be differentiated from function...

Diagnosis of periprosthetic joint infections of the hip and knee.
https://doi.org/10.5435/00124635-201012000-00006
The Journal of the American Academy of Orthopaedic Surgeons; Della Valle C, Parvizi J et. al.

Dec 2nd, 2010 - No preferred test for diagnosis of periprosthetic joint infection exists, and the algorithm for the workup of patients suspected of infection remains unclear. The work group evaluated the available literature to determine the role of each diagnost...

see more →

Drugs  6 results see all →

Clinicaltrials.gov  63 results

A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT04276649

Sep 14th, 2021 - The research has been approved by the Medical Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University. According to the "Consensus on Diagnosis and Treatment of Inflammatory Bowel Disease" formulated by the Beijing Confere...

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
https://clinicaltrials.gov/ct2/show/NCT02874430

Sep 1st, 2021 - PRIMARY OBJECTIVES: I. To determine if treatment with a combination of metformin and doxycycline can increase the percentage of cells that express Caveolin-1 in the cancer associated fibroblasts of patients with breast, or uterine, and cervical ca...

Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection
https://clinicaltrials.gov/ct2/show/NCT01150721

Aug 23rd, 2021 - In this protocol, a repeated measure design is used to examine microbial and molecular results in subjects with a diagnosis of pulmonary nontuberculous mycobacterial infection. Patients often experience difficulties in the spontaneous expectoratio...

Berberine Chloride in Preventing Colorectal Cancer in Patients With Ulcerative Colitis in Remission
https://clinicaltrials.gov/ct2/show/NCT02365480

Aug 3rd, 2021 - PRIMARY OBJECTIVES: I. To determine the safety of berberine (berberine chloride) administered to participants with ulcerative colitis (UC) in clinical remission while receiving maintenance therapy with mesalamine. SECONDARY OBJECTIVES: I. Determin...

Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients
https://clinicaltrials.gov/ct2/show/NCT04872556

Aug 2nd, 2021 - The current clinical study is prospectively randomized and double-blinded, and practice in Chang Gung Memorial Hospital in Linkou, TaoYuan and Taipei branches. All 90 participants suffered from taxanes-induced myalgia and Arthralgia, and will be r...

see more →

News  340 results

Cavitary Lung Lesion in a Tuberculosis-Negative Patient
https://www.mdedge.com/fedprac/article/247212/pulmonology/cavitary-lung-lesion-tuberculosis-negative-patient
LT Michael C. Harding, MD, USPHS, Capt Steven J. Gibson, MD, USAF et. al.

Oct 8th, 2021 - A patient with worsening chronic cough, shortness of breath, and hemoptysis tested negative for tuberculosis; but a chest computed tomography scan showed an upper left lobe cavitary lesion. A 71-year-old, currently homeless male veteran with a 29.

Taper, withdrawal of RA meds tested in real-life randomized trial setting
https://www.mdedge.com/rheumatology/article/247158/rheumatoid-arthritis/taper-withdrawal-ra-meds-tested-real-life
Heidi Splete

Oct 7th, 2021 - About half of patients with rheumatoid arthritis who taper or stop disease-modifying antirheumatic drugs (DMARDs) retain stable remission after 12 months, and a majority of those who do relapse regain remission when back on their original treatmen.

Researchers Follow Development of Axial SpA in First-Degree Relatives of Patients
https://www.medscape.com/viewarticle/954492

Jul 9th, 2021 - Healthy first-degree relatives of individuals with HLA-B27–positive axial spondyloarthritis who also were HLA-B27 positive were at increased risk for developing the disease themselves within 1 year, based on data from an ongoing prospective cohort...

RA: Tofacitinib modified-release 11 mg OD plus methotrexate shows promise in ORAL Shift trial
https://www.mdedge.com/rheumatology/article/242068/rheumatoid-arthritis/ra-tofacitinib-modified-release-11-mg-od-plus

Jun 24th, 2021 - Key clinical point: ORAL Shift demonstrates safety and efficacy of tofacitinib modified-release 11 mg once daily (OD) plus methotrexate in a global population of patients with rheumatoid arthritis (RA). Major finding: All efficacy outcomes improve.

Foot rash and joint pain
https://www.mdedge.com/familymedicine/article/241784/dermatology/foot-rash-and-joint-pain
MDedge Family Medicine; Hannah R. Badon, MD, Ross L. Pearlman, MD et. al.

Jun 18th, 2021 - A 21-year-old man presented to the emergency department (ED) with a 2-month history of joint pain, swelling, and difficulty walking that began with swelling of his right knee (FIGURE 1A). The patient said that over the course of several weeks, the.

see more →

Patient Education  12 results see all →